Joint clinical projects


The aim of the BMBF joint project AwareMe is to develop a modular and interactive medical technology that supports the self-management of behavioural disorders for young adults unobtrusively in everyday life. For example, body-worn medical technology for ADHD is being developed here. The symptoms relevant to the behavioural disorder are detected both in inconspicuous worn sensors and by smartphone-based experience sampling.

For more information on the AwareMe project, click here.


As a sub-project of the BMBF-funded ESCAlife joint project, ESCAlate focuses on the treatment of ADHD in young adults. The concrete goal of ESCAlate is to investigate the effectiveness of an adaptive and gradual treatment program, which is based on three different treatment methods: Psychopharmaceutical therapy, neurofeedback training and psychoeducation.

Patients with ADHD are welcome to participate in an ongoing study. The contact person is Maria Steffens (

More detailed information about the ESCAlate project can be found here.


ADHD treatment in adults usually consists of an drug and/or psychotherapeutic treatment, whereby the drug treatment success is usually higher than the psychotherapeutic treatment success. However, drug ADHD treatment often leads to undesirable side effects and must also be closely monitored. The development of further, effective and low-side ADHD therapy approaches therefore appears to be urgently indicated. The aim of the BMBF-funded ATTENTION project is to develop a novel medical-technical system for targeted neuromodulation of attention-associated cortical networks through electrostimulation.

More detailed information about the ATTENTION project can be found here.